Summary
The anti-inflammatory drug indomethacin was tested for antitumor activity against transplantable mouse colon adenocarcinoma 38 (colon 38). Groups of BDF1 mice (C57BL/6xDBA/2) were given intraperitoneal injections of this drug beginning on the 6th day after subcutaneous implantation of the tumor and continued for 4 to 8 days. In other groups of mice, identical treatment was delayed until the 16th day after implation of the tumor. The higher antitumor activity against colon 38 was obtained with earlier initiation of treatment, indicated by decreased growth of the tumor and increased life span of the host. The later initiation of the treatment produced less antitumor activity. The antitumor activity was, however, less than that of 5-fluorouracil, which was used as a positive control drug. The two drugs in combination produced few advantages over 5-fluorouracil alone using the dose schedule designed in the present experiment. Indomethacin treatment significantly reduced prostaglandin E and F levels in the tumor tissue, but 5-fluorouracil did not. It seems likely that the inhibition of prostaglandin biosynthesis by indomethacin underlies the antitumor effect of this drug on colon 38.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- Colon 38:
-
transplantable mouse colon adenocarcinoma 38
- 5-FU:
-
5-fluorouracil
- PG:
-
prostaglandin
References
Bankhurst AD (1982) The modulation of human natural killer cell activity by prostaglandins. J Clin Lab Immunol 7:85–91
Bayer BM, Kruth HS, Vaughan M, Beaven MA (1979) Arrest of cultured cells in G1 phase of the cell cycle by indomethacin. J Pharmacol Exp Therap 210:106–111
Bennett A, Deltacca M, Stamford IF, Zebro T (1977) Prostaglandins from tumors of human large bowel. Br J Cancer 35:881–884
Bennett A, Houghton J, Leaper DJ, Stamford IF (1979) Cancer growth, response to treatment and survival time in mice; benefical effect of the prostaglandin synthesis inhibitor flurbiprofen. Prostaglandins 17:179–191
Bennett A, Berstock DA, Carroll MA (1982) Increased survival of cancer-bearing mice treated with inhibitors of prostaglandin synthesis alone or with chemotherapy. Br J Cancer 45:762–768
Boorman GA, Luster MI, Dean JH, Luebke RW (1982) Effect of indomethacin on the bone marrow and immune system of the mouse. J Clin Lab Immunol 7:119–126
Corbett TH, Griswold DP, Roberts BJ, Peckham JC, Schabel FM (1977) Evaluation of single agents and combinations of chemotherapeutic agents in mouse colon carcinomas. Cancer 40:2660–2680
Droller MJ, Perlmann P, Schneiden MU (1978) Enhancement of natural and antibody-dependent lymphocyte cytotoxicity by drugs which inhibit prostaglandin production by tumor target cells. Cell Immunol 39:154–164
Fulton AM, Levy JG (1980) Inhibition of murine tumor growth and prostaglandin synthesis by indomethacin. Int J Cancer 26:669–673
Gatenby P, Basten A, Creswick P (1980) A mouse model for Immunotherapy of osteosarcoma. III. Combined therapy with Corynebacterium parvum and prostaglandin synthetase inhibitors. Cancer Immunol Immunother 9:245–253
Hial V, Horakova Z, Shaff RE, Beaven MA (1976) Alteration of tumor growth by aspirin and indomethacin: Studies with two transplantable tumors in mouse. Eur J Pharmacol 37:367–376
Hial V, Demello MCF, Horakova Z, Beaven MA (1977) Antiproliferative activity of anti-inflammatory drugs in two mammalian cell culture lines. J Pharmacol Exp Ther 202:446–454
Hofer D, Dubitsky AM, Reilly P, Santoro MG, Jaffe BM (1980) The interactions between indomethacin and cytotoxic drugs in mice bearing B-16 melanoma. Prostaglandins 20:1033–1039
Humes JL, Bonney RJ, Pelus L, Dahlgren ME, Sadowski SJ, Kuehl FA Jr, Davies P (1977) Macrophages synthesize and release prostaglandins in response to inflammatory stimuli. Nature 269:149–151
Jaffe BM, Behrman HR, Parker CW (1973) Radioimmunoassay measurement of prostaglandins A and F in human plasma. J Clin Invest 52:398–405
Kudo T, Narisawa T, Abo S (1980) Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumors in rats. Gann 71:260–264
Lupulescu A (1978) Enhancement of carcinogenesis by prostaglandins. Nature 272:634–636
Lynch NR, Castes M, Astoin M, Salomon JC (1978) Mechanism of inhibition of tumor growth by aspirin and indomethacin. Br J Cancer 38:503–511
Lynch NR, Salomon JC (1979) Tumor growth inhibition and potentiation of immunotherapy by indomethacin in mice. J Natl Cancer Inst 62:117–121
Maca RD, Panje WR (1982) Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and postirradiation therapy. Cancer 50:483–489
Narisawa T, Sato M, Tani M, Takahashi T, Goto A (1981) Inhibition of development of methylnitrosourea-induced rat colon tumors by indomethacin treatment. Cancer Res 41:1954–1957
Narisawa T, Sato M, Sano M, Takahashi T (1982) Inhibition of development of methylnitrosourea-induced rat colonic tumors by peroral administration of indomethacin. Gann 73:377–381
Plescia OJ, Smith AH, Grinwich K (1975) Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci USA 72:1848–1851
Schultz RM, Pavlidis NA, Stylos WA, Chirigas MA (1978) Regulation of macrophage tumoricidal function: A role for prostaglandins of the E series. Science 202:320–321
Strausser H, Humes JL (1975) Prostaglandin synthesis inhibition: Effect on bone change and sarcoma tumor induction in BALB/C mice. Int J Cancer 15:724–730
Taffect SM, Russell SW (1981) Macrophage-mediated tumor cell killing: Regulation of expression of cytolytic activity by prostaglandin E. J Immunol 126:424–427
Tashjian AJ Jr, Voelhel EF, Goldhabec P, Levine L (1974) Prostaglandins, calcium metabolism and cancer. Fed Proc 33:81–86
Thomas DR, Philpott GW, Jaffe BM (1974) The relationship between concentration of Prostaglandin E and rate of cell proliferation. Exp Cell Res 84:40–46
Trevisani A, Ferretiti E, Capuzzo A, Tomasi V (1980) Elevated levels of prostaglandin E2 in Yoshida hepatoma and the inhibition of tumor growth by non-steroidal anti-inflammatory drugs. Br J Cancer 41:341–347
Author information
Authors and Affiliations
Additional information
Supported in part by a Grant-in-Aid for cancer research from the Ministry of Education, Science and Culture and from the Ministry of Health and Welfare, Japan
Rights and permissions
About this article
Cite this article
Sato, M., Narisawa, T., Sano, M. et al. Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin. J Cancer Res Clin Oncol 106, 21–26 (1983). https://doi.org/10.1007/BF00399893
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00399893